METTL3 and lung carcinoma: METTL3 itself participates in controlling the translation of some m6A-containing mRNAs, such as the epidermal growth factor receptor, and the expression of the Hippo pathway effector TAZ, thus affecting Myc and RAS levels in lung cancer independently of m6A reader proteins (34).